GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Mapk9 | decreases phosphorylation | EXP | | 6480464 | CTD | pyrazolanthrone results in decreased phosphorylation of MAPK9 protein | PMID:22085843 | Mapk9 | multiple interactions | EXP | | 6480464 | CTD | pyrazolanthrone inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [nickel chloride results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Paraquat results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [pentaacetyl geniposide results in increased phosphorylation of MAPK9 protein] | PMID:16687388 PMID:17651887 PMID:19038359 PMID:21843586 PMID:22085843 PMID:27174766 PMID:28474156 PMID:31348969 | Mapk9 | decreases activity | ISO | MAPK9 (Homo sapiens) | 6480464 | CTD | pyrazolanthrone results in decreased activity of MAPK9 protein | PMID:12534346 | Mapk9 | decreases phosphorylation | ISO | MAPK9 (Homo sapiens) | 6480464 | CTD | pyrazolanthrone results in decreased phosphorylation of MAPK9 protein | PMID:34076342 | Mapk9 | multiple interactions | ISO | MAPK9 (Homo sapiens) | 6480464 | CTD | pyrazolanthrone inhibits the reaction [5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [arsenic trichloride results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [diethyl maleate results in increased expression of MAPK9 protein modified form]; pyrazolanthrone inhibits the reaction [LY 293111 results in increased expression of MAPK9 protein modified form]; pyrazolanthrone inhibits the reaction [o,p'-DDT results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Paraquat results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Plant Extracts results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [polyphyllin I results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Resveratrol results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [sanguinarine results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Silicon Dioxide results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Silybin results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK9 protein]; pyrazolanthrone inhibits the reaction [TNF protein results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone promotes the reaction [dehydrocrenatidine results in decreased phosphorylation of MAPK9 protein] | PMID:15322261 PMID:15831436 PMID:16151469 PMID:16777994 PMID:18347188 PMID:18412143 PMID:18728404 PMID:19135517 PMID:20206247 PMID:20678559 PMID:22696236 PMID:26385185 PMID:28474156 PMID:30261343 PMID:31421117 PMID:33075463 PMID:34076342 PMID:35689653 | Mapk9 | multiple interactions | ISO | Mapk9 (Mus musculus) | 6480464 | CTD | pyrazolanthrone inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [o,p'-DDT results in increased phosphorylation of and results in increased activity of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Triclosan results in increased phosphorylation of MAPK9 protein] | PMID:18840457 PMID:25531190 PMID:29906494 PMID:33075463 PMID:34160118 | |
Go Back to source page | Continue to Ontology report |